Immunoglobulins from sera of APS patients bind HTR-8/SVneo trophoblast cell line and reduce additional mediators of cell invasion

Reprod Biol. 2017 Dec;17(4):389-395. doi: 10.1016/j.repbio.2017.10.006.

Abstract

Immunoglobulins from sera of patients with antiphospholipid syndrome (APS) decrease trophoblast cell invasion in vitro. This study aimed to extend understanding of cellular effects of immunoglobulins from APS (aPL+) in HTR-8/SVneo cells. aPL+ IgG induced change in effector molecules important for cell invasion was investigated further. After 1h of culture 21% cells bound aPL+ IgG, as opposed to 6% in control (aPL-). This was accompanied by increase in phospho-p38 at 30min. After 24h treatment aPL+IgG decreased protein levels of integrin subunits α1 (78% of control; p<0.01), α4 (65% of control, p<0.01), α5 (76% of control; p<0.01) and β1 (80% of control; p<0.01), and secreted gal-1 (68% of control; p<0.05). ProMMP-9 was reduced to 70% of control (p<0.001). Treatment with inhibitor of p38 MAPK signaling SB202190 reversed inhibition in integrin β1 and secreted gal-1. Involvement of p38 MAPK signaling and decrease in integrin subunit α4, proMMP-9, and secreted gal-1 in HTR-8/SVneo cells are novel and extend the list of mediators of trophoblast invasion affected by aPL.

Keywords: Antiphospholipid antibodies; HTR-8/SVneo cell line; Integrins; MMP-9; p38 MAPK.

MeSH terms

  • Antiphospholipid Syndrome / immunology*
  • Cell Line
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Imidazoles / pharmacology
  • Immunoglobulins / metabolism*
  • Integrins / metabolism
  • Phosphorylation / drug effects
  • Pyridines / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Trophoblasts / drug effects
  • Trophoblasts / metabolism*

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Immunoglobulins
  • Integrins
  • Pyridines
  • 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole